Predictive factors for adverse pregnancy outcomes after renal transplantation

Clinical Transplantation

Volumn 28, Issue 6, 2014, Pages 699-706

  You, Ji Yeon ^a   Kim, Moon Kyung ^a   Choi, Suk Joo ^a   Oh, Soo Young ^a   Kim, Sung Joo ^a   Kim, Jong Hwa ^a   Oh, Ha Young ^a   Roh, Cheong Rae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adverse pregnancy outcome; Pre eclampsia; Renal transplantation; Serum creatinine

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ADVERSE PREGNANCY RELATED OUTCOMES INDEX; ARTICLE; CESAREAN SECTION; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FETUS WASTAGE; FOLLOW UP; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY TRANSPLANTATION; LOW BIRTH WEIGHT; MATERNAL AGE; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; RISK FACTOR; UNPLANNED PREGNANCY; BLOOD; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS;

ADULT; CREATININE; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84901929259     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12367     Document Type: Article

References (15)

1. Murray JE, Reid DE, Harrison JH, Merrill JP. Successful pregnancies after human renal transplantation. N Engl J Med 1963: 269: 341.
2. Davison JM, Lind T, Uldall PR. Planned pregnancy in a renal transplant recipient. Br J Obstet Gynaecol 1976: 83: 518.
3. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National transplantation Pregnancy Registry-Outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1994: 57: 502.
4. Sibanda N, Briggs JD, Davison JM, Johnson RJ, Rudge CJ. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation 2007: 83: 1301.
5. Davison JM, Bailey DJ. Pregnancy following renal transplantation. J Obstet Gynaecol Res 2003: 29: 227.
6. Mckay DB, Josephson MA, Armenti VT et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005: 5: 1592.
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999: 130: 461.
8. McKay DB, Josephson MA. Pregnancy in recipients of solid organs - effects on mother and child. N Engl J Med 2006: 354: 1281.
9. Armenti VT, Radomski JS, Moritz MJ et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2004: 103.
10. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009: 200: 481 e1.
11. White CA, Huang D, Akbari A, Garland J, Knoll GA. Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review. Am J Kidney Dis 1005: 2008: 51.
12. Abe T, Ichimaru N, Okumi M et al. Pregnancy after renal transplantation: a single-center experience. Int J Urol 2008: 15: 587.
13. Kato M, Hattori R, Kinukawa T, Kamihira O, Yamada S, Gotoh M. Correlation between treated hypertension in prepregnancy and transplanted kidney function deterioration during pregnancy even if within pregnancy permission criteria. Transplant Proc 2012: 44: 635.
14. Roche Laboratories. Mycophenolate Mofetil Package Insert. Nutley, NJ: Roche Laboratories, Inc., 2007.
15. Perez-Aytes A, Ledo A, Boso V et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet A 2008: 146A: 1.